
Interactive online tool, Vision Simulator, highlights vision loss caused by retinal diseases
The tool shows disease progression and vision loss simulations for multiple diseases such as AMD, XLRP, and achromatopsia
It’s an old adage that knowledge is power, which is especially true when it comes to health. By receiving a diagnosis, patients gain knowledge of how their condition may progress as well as any treatments that can prevent or reverse symptoms. Understanding a condition can empower family members and caregivers to better assist those who may be experiencing low vision or vision loss. Researchers work to understand diseases to better develop treatments and provide better outcomes for patients.
Seeing through patients’ eyes
Online tools can empower those who are experiencing vision changes to understand their condition as well as communicate their lived experience with those around them. One such online tool providing this knowledge is the
The
Gaining knowledge through retinal research
This introduction to common retinal conditions is part of the larger goals in the pharmaceutical and ophthalmic community. Janssen is in the process of developing gene therapies for inherited retinal diseases, such as achromatopsia and XLRP, as well as geographic atrophy caused by AMD.2
Several other companies, including 4DMT, Adverum, Alvotech, EyePoint Pharmaceuticals, and Ocular Therapeutix, have also focused on
The value of this research is not only a hope for the future for patients currently facing decreasing vision and blinding conditions but also for those who have yet to develop or be diagnosed with such conditions. By continuing to conduct trials, understand the mechanisms of disease, and communicate clearly with patients about the nature of their conditions and treatment options, the ophthalmic community is gaining knowledge, empowering each other, and working toward a future with better sight for all.
References
Experience the Vision Simulator. Janssen. Accessed April 15, 2024. https://www.retina.janssen.com/vision-simulator
Janssen Retina’s research dares to envision a world of healthy sight. Janssen. Accessed April 15, 2024. https://www.retina.janssen.com/our-research
Crago SM. Clinical trials: companies tackle AMD in early 2024. Modern Retina. April 2, 2024. Accessed April 18,2024. https://www.modernretina.com/view/clinical-trials-companies-tackle-amd-in-early-2024
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.